Table 2 |
|||||
|
Intracellular micromolar concentrations of NAD+ metabolites and related nucleosides and nucleotides as a function of medium components |
|||||
|
Metabolite |
SDC-NA |
SDC |
YPD |
YPD0.5 |
YPD0.2 |
|
|
|||||
|
Nam |
1.5 ± 0.2*† |
31.6 ± 3.0 |
35.0 ± 3.2 |
29.7 ± 0.3 |
51.9 ± 17.9 |
|
NA |
<0.5 |
<0.5 |
<0.5 |
<0.5 |
<0.5 |
|
Cyt |
1.8 ± 0.2† |
1.5 ± 0.2† |
69.5 ± 11.5 |
42.2 ± 9.1 |
63.4 ± 13.5 |
|
Urd |
5.3 ± 1.4† |
13.0 ± 3.0† |
139.7 ± 0.6 |
141.7 ± 0.2 |
128.7 ± 7.0 |
|
NR |
2.1 ± 0.3*† |
4.6 ± 0.9† |
9.3 ± 0.4 |
7.9 ± 1.5 |
7.1 ± 1.4 |
|
NAR |
0.2 ± 0.0*† |
8.1 ± 1.3 |
12.5 ± 0.2 |
8.3 ± 1.7 |
8.4 ± 0.7† |
|
Ino |
21.8 ± 1.7*† |
6.0 ± 0.4† |
54.9 ± 2.6 |
38.5 ± 3.3† |
31.8 ± 3.3† |
|
CMP |
31.5 ± 1.5 |
39.7 ± 9.1 |
146.4 ± 16.7 |
134.8 ± 45.1 |
165.3 ± 38.3 |
|
UMP |
63.0 ± 7.0*† |
145.4 ± 27.9 |
179.6 ± 2.7 |
238.0 ± 20.9 |
236.6 ± 23.2 |
|
NMN |
19.0 ± 1.9*† |
67.3 ± 13.0 |
62.1 ± 13.7 |
60.0 ± 14.8 |
72.4 ± 21.2 |
|
NaMN |
2.9 ± 0.2*† |
28.0 ± 4.5 |
11.6 ± 2.0 |
18.4 ± 4.3 |
21.1 ± 3.7 |
|
IMP |
8.4 ± 0.3 |
7.1 ± 1.8 |
16.8 ± 6.3 |
16.1 ± 1.5 |
16.1 ± 1.5 |
|
NAD+ |
277.2 ± 26.7* |
513.9 ± 51.1 |
438.5 ± 66.7 |
308.9 ± 33.8 |
339.5 ± 11.7 |
|
NaAD |
<0.1 |
<0.1† |
3.8 ± 0.3 |
<0.1† |
<0.1† |
|
NADH |
125.8 ± 13.6*† |
207.3 ± 17.1 |
263.0 ± 55.3 |
101.2 ± 24.6 |
152.0 ± 12.7 |
|
NADP |
31.2 ± 1.4 |
31.1 ± 3.5 |
46.9 ± 10.2 |
42.9 ± 7.2 |
52.5 ± 2.1 |
|
NADPH |
0.3 ± 0.1* |
3.1 ± 0.6 |
0.7 ± 0.2 |
1.3 ± 0.1 |
3.0 ± 0.2†‡ |
|
|
|||||
|
* indicates a significant difference when compared to cells grown in SDC. † indicates a significant difference when compared to cells grown in YPD. ‡ indicates a significant difference between cells grown in YPD 0.5 and YPD 0.2% glucose. |
|||||
|
Evans et al. BMC Chemical Biology 2010 10:2 doi:10.1186/1472-6769-10-2 |
|||||